IMO as a LT holder, i think that the next 4 weeks are critical to me. With "MB at the helm", he better earn his $50k/pa board fee (before he became an Executive Chairman that is). He has been hitting the phones hard this afternoon I think which may be reflective in the SP.
I'm really at a review point with ACL, but i'm really hoping for the following:
1. P3 patient closure.
2. SLC P2 update.
3. Audeo future clarified.
4. Upwards trending Fonda revenue (to support a non CR)
5. No selling the company for a under valued share price considering the potential.
If most of the above announcements are crap or not in the next 4 weeks, then i'm finally out.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.409M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| TSN (ASX) Chart |
Day chart unavailable